berotek has been researched along with MS (Multiple Sclerosis) in 2 studies
Fenoterol: A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
fenoterol : A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction.
Excerpt | Relevance | Reference |
---|---|---|
" The dose-response relationship was similar within the non-asthma patients." | 1.40 | Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study. ( Lee, CT; Lin, FC; Tsai, CP, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yong, HY | 1 |
McKay, KA | 1 |
Daley, CGJ | 1 |
Tremlett, H | 1 |
Tsai, CP | 1 |
Lin, FC | 1 |
Lee, CT | 1 |
1 review available for berotek and MS (Multiple Sclerosis)
Article | Year |
---|---|
Drug exposure and the risk of multiple sclerosis: A systematic review.
Topics: Adrenergic beta-2 Receptor Agonists; Antirheumatic Agents; Fenoterol; Histamine H1 Antagonists; Huma | 2018 |
1 other study available for berotek and MS (Multiple Sclerosis)
Article | Year |
---|---|
Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study.
Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Adult; Albuterol; Case-Control Studies; Child; Chil | 2014 |